Sandoz Biosimilar Etanercept Recommended By Fda For Approval To Treat Multiple Inflammatory Diseases
Sandoz, a Novartis division and leader in biosimilars, announced today that the US FDA Advisory Committee recommended approval of its...
Sandoz, a Novartis division and leader in biosimilars, announced today that the US FDA Advisory Committee recommended approval of its...
Bayer and X-Chem, Inc focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics,...
AbbVie a global biopharmaceutical company, announced that the U.S. FDA granted Rare Pediatric Disease Designation for ABT-414, an investigational antibody...
Alexion Pharmaceuticals Inc announced that the Company will report its financial results for the second quarter ended June 30, 2016...
Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg), the...
Automated compounding systems from RIVA prepare syringes and IV bags in an aseptic ISO Class 5 environment. ARxIUM, developer...
Bristol-Myers Squibb Company and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of...
Pfizer Inc. will invest $350 million in eastern China on a plant for biotechnology drugs, bolstering its presence in the...
3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform ...
Sanofi announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) in connection with...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.